MarketBeat Instant News Alerts 2 hours agoCompass Therapeutics, Inc. (NASDAQ:CMPX) Stock Has Average Target Price of $10.21MarketBeatShares of Compass Therapeutics, Inc. (NASDAQ:CMPX - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the seventeen analysts that are currently covering the company, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation, three haNASDAQ:CMPXRead Compass Therapeutics, Inc. (NASDAQ:CMPX) Stock Has Average Target Price of $10.212 hours agoHome BancShares, Inc. (NYSE:HOMB) Receives Consensus Rating of "Moderate Buy" from BrokeragesMarketBeatHome BancShares, Inc. (NYSE:HOMB - Get Free Report) has been given a consensus rating of "Moderate Buy" by the nine ratings firms that are presently covering the firm, MarketBeat Ratings reports. Four investment analysts have rated the stock with a hold recommendation and five have given a buy recomNYSE:HOMBRead Home BancShares, Inc. (NYSE:HOMB) Receives Consensus Rating of "Moderate Buy" from Brokerages2 hours agoH. B. Fuller Company (NYSE:FUL) Stock Has Consensus Target Price of $64.62 According to BrokeragesMarketBeatShares of H. B. Fuller Company (NYSE:FUL - Get Free Report) have received a consensus rating of "Moderate Buy" from the eight ratings firms that are covering the firm, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold rating, four have issued a buy rating and NYSE:FULRead H. B. Fuller Company (NYSE:FUL) Stock Has Consensus Target Price of $64.62 According to Brokerages2 hours agogoeasy Ltd. (TSE:GSY) Receives Average Rating of "Reduce" from BrokeragesMarketBeatgoeasy Ltd. (TSE:GSY - Get Free Report) has earned a consensus rating of "Reduce" from the nine brokerages that are currently covering the company, Marketbeat reports. Two investment analysts have rated the stock with a sell rating, six have assigned a hold rating and one has given a buy rating to tTSE:GSYRead goeasy Ltd. (TSE:GSY) Receives Average Rating of "Reduce" from Brokerages2 hours agoFirst Busey Corporation (NASDAQ:BUSE) Stock Has Average Price Target of $31.00MarketBeatFirst Busey Corporation (NASDAQ:BUSE - Get Free Report) has received an average rating of "Hold" from the seven ratings firms that are currently covering the stock, MarketBeat.com reports. Four research analysts have rated the stock with a hold recommendation and three have issued a buy recommendatiNASDAQ:BUSERead First Busey Corporation (NASDAQ:BUSE) Stock Has Average Price Target of $31.002 hours agoZurn Elkay Water Solutions Cor (NYSE:ZWS) Stock Now Rated "Moderate Buy" by Sell-Side AnalystsMarketBeatZurn Elkay Water Solutions Cor (NYSE:ZWS - Get Free Report) has been given a consensus rating of "Moderate Buy" by the nine ratings firms that are presently covering the stock, MarketBeat.com reports. Three research analysts have rated the stock with a hold rating, five have given a buy rating and oNYSE:ZWSRead Zurn Elkay Water Solutions Cor (NYSE:ZWS) Stock Now Rated "Moderate Buy" by Sell-Side Analysts Trending News1Rivian Eyes Late-Year Autonomy Rollout as R2 Production Ramp Takes Center Stage2NIKE Q1 Earnings Call Highlights3Rocket Lab (NASDAQ:RKLB) Stock Jumps 6.2% - Here's Why4IREN (NASDAQ:IREN) Stock Falls 1.2% on Analyst Downgrade5Cerebras Systems (NASDAQ:CBRS) Shares Gap Down - Here's What Happened6Energy Transfer (NYSE:ET) Stock Falls 1.1% - What's Next?7Dutch Bros (NYSE:BROS) Stock Price Target Cut by Jefferies Financial Group8Intel Corporation $INTC Stock Sold by Greenwich Wealth Management LLC All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 5 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Corporate Event Transcript Dividend Earnings Earnings Preview Earnings Transcript Highlights Estimates Guidance Insider Trade Lockup Expiration MarketBeat List Articles Options Price SEC Filing Stock List Stock Split Alert Type Keywords 2 hours agoNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Stock Has Average Price Target of $34.50 According to BrokeragesMarketBeatNASDAQ:NRXPRead NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Stock Has Average Price Target of $34.50 According to Brokerages2 hours agoGrindr Inc. (NYSE:GRND) Receives Average Rating of "Moderate Buy" from AnalystsMarketBeatNYSE:GRNDRead Grindr Inc. (NYSE:GRND) Receives Average Rating of "Moderate Buy" from Analysts2 hours agoBlack Diamond Therapeutics, Inc. (NASDAQ:BDTX) Stock Has Consensus Target Price of $10.25MarketBeatNASDAQ:BDTXRead Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Stock Has Consensus Target Price of $10.252 hours agoProFrac Holding Corp. (NASDAQ:ACDC) Stock Has Consensus Price Target of $5.25MarketBeatNASDAQ:ACDCRead ProFrac Holding Corp. (NASDAQ:ACDC) Stock Has Consensus Price Target of $5.252 hours agoOncobiologics, Inc. (NASDAQ:OTLK) Receives Consensus Rating of "Hold" from BrokeragesMarketBeatNASDAQ:OTLKRead Oncobiologics, Inc. (NASDAQ:OTLK) Receives Consensus Rating of "Hold" from Brokerages2 hours agoYext (NYSE:YEXT) Stock Has Average Target Price of $6.33MarketBeatNYSE:YEXTRead Yext (NYSE:YEXT) Stock Has Average Target Price of $6.332 hours agoJinkoSolar Holding Company Limited (NYSE:JKS) Stock Has Average Price Target of $19.88MarketBeatNYSE:JKSRead JinkoSolar Holding Company Limited (NYSE:JKS) Stock Has Average Price Target of $19.882 hours agoGain Therapeutics, Inc. (NASDAQ:GANX) Stock Has Average Price Target of $7.50MarketBeatNASDAQ:GANXRead Gain Therapeutics, Inc. (NASDAQ:GANX) Stock Has Average Price Target of $7.502 hours agoAbsci Corporation (NASDAQ:ABSI) Stock Has Average Target Price of $13.71MarketBeatNASDAQ:ABSIRead Absci Corporation (NASDAQ:ABSI) Stock Has Average Target Price of $13.712 hours agoPyxis Oncology, Inc. (NASDAQ:PYXS) Receives Consensus Rating of "Moderate Buy" from AnalystsMarketBeatNASDAQ:PYXSRead Pyxis Oncology, Inc. (NASDAQ:PYXS) Receives Consensus Rating of "Moderate Buy" from Analysts2 hours agoIDEAYA Biosciences, Inc. (NASDAQ:IDYA) Receives Consensus Rating of "Moderate Buy" from AnalystsMarketBeatNASDAQ:IDYARead IDEAYA Biosciences, Inc. (NASDAQ:IDYA) Receives Consensus Rating of "Moderate Buy" from Analysts2 hours agoiQIYI, Inc. Sponsored ADR (NASDAQ:IQ) Stock Has Consensus Price Target of $1.73MarketBeatNASDAQ:IQRead iQIYI, Inc. Sponsored ADR (NASDAQ:IQ) Stock Has Consensus Price Target of $1.732 hours agoRedwire Corporation (NYSE:RDW) Stock Rated "Hold" by Wall Street BrokeragesMarketBeatNYSE:RDWRead Redwire Corporation (NYSE:RDW) Stock Rated "Hold" by Wall Street Brokerages2 hours agoFinning International Inc. (TSE:FTT) Receives Average Recommendation of "Buy" from AnalystsMarketBeatTSE:FTTRead Finning International Inc. (TSE:FTT) Receives Average Recommendation of "Buy" from Analysts2 hours agoHinge Health Inc. (NYSE:HNGE) Stock Has Average Price Target of $105.33 According to BrokeragesMarketBeatNYSE:HNGERead Hinge Health Inc. (NYSE:HNGE) Stock Has Average Price Target of $105.33 According to Brokerages2 hours agoMNTN Inc. (NYSE:MNTN) Stock Has Average Price Target of $18.65 According to AnalystsMarketBeatNYSE:MNTNRead MNTN Inc. (NYSE:MNTN) Stock Has Average Price Target of $18.65 According to Analysts2 hours agoRafael’s Trappsol Cyclo Misses Primary Endpoint, Targets 2026 FDA FilingMarketBeatNYSE:RFLRead Rafael’s Trappsol Cyclo Misses Primary Endpoint, Targets 2026 FDA Filing3 hours agoWolverine World Wide (NYSE:WWW) Stock Rating Raised to "Buy" at Wall Street ZenMarketBeatNYSE:WWWRead Wolverine World Wide (NYSE:WWW) Stock Rating Raised to "Buy" at Wall Street Zen3 hours agoUnity Software (NYSE:U) Rating Lowered to "Hold" at Wall Street ZenMarketBeatNYSE:URead Unity Software (NYSE:U) Rating Lowered to "Hold" at Wall Street Zen3 hours agoAsana (NYSE:ASAN) Upgraded to "Buy" at Wall Street ZenMarketBeatNYSE:ASANRead Asana (NYSE:ASAN) Upgraded to "Buy" at Wall Street Zen3 hours agoWall Street Zen Downgrades Immunome (NASDAQ:IMNM) to Strong SellMarketBeatNASDAQ:IMNMRead Wall Street Zen Downgrades Immunome (NASDAQ:IMNM) to Strong Sell3 hours agoEVE (NYSE:EVEX) Rating Lowered to "Strong Sell" at Wall Street ZenMarketBeatNYSE:EVEXRead EVE (NYSE:EVEX) Rating Lowered to "Strong Sell" at Wall Street Zen3 hours agoAirbnb (NASDAQ:ABNB) Rating Lowered to "Hold" at Wall Street ZenMarketBeatNASDAQ:ABNBRead Airbnb (NASDAQ:ABNB) Rating Lowered to "Hold" at Wall Street Zen3 hours agoWall Street Zen Upgrades Edgewise Therapeutics (NASDAQ:EWTX) to HoldMarketBeatNASDAQ:EWTXRead Wall Street Zen Upgrades Edgewise Therapeutics (NASDAQ:EWTX) to Hold Featured Articles and OffersDeutsche Bank Makes a Contrarian Call on Netflix—What Does It Mean for Investors?By Sam Quirke | September 30, 2026Here’s the stock symbol I’ve promisedFrom Stansberry Research (Ad)Six Flags Launches FlexPay—Is There Any FUN Left in the Stock?By Chris Markoch | September 28, 2026Data Centers Got the AI Hype—But Office REITs May Get the Rent HikesBy Chris Markoch | September 27, 2026Everyone in AI Is Quietly Copying Palantir's PlaybookBy Chris Markoch | October 1, 2026$0. Later: $29.97.From Profits Run (Ad)CarMax Just Gave Investors a Better Reason to Believe in the TurnaroundBy Thomas Hughes | September 29, 20265 Scary-Good Stocks With Strong October Catalysts and Breakout PotentialBy Thomas Hughes | September 27, 2026 Alert CategoriesAll AlertsAnalystCongressional TradesConsensusCorporate BuybackCorporate Event TranscriptStock ListDividendEarningsEarnings PreviewEarnings Transcript HighlightsEstimatesGuidanceInsider TradeLockup ExpirationMarketBeat List ArticlesOptionsPriceSEC FilingStock Split Page 1 of 193 1234567 Earlier › Earliest » Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
